Andrea Park
Net worth: - $ as of 2026-03-30
Net worth: - $ as of 2026-03-30
Ms. Andrea E.
Park was previously employed as a Chief Financial Officer by AlphaTON Capital Corp., a Chief Financial Officer by AgeX Therapeutics, Inc., a Vice President-Finance & Controller by Lineage Cell Therapeutics, Inc., and a Chief Financial & Accounting Officer by Serina Therapeutics, Inc. She received her undergraduate degree from the University of California.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-07-20 | 0 ( -.--% ) | - $ | 2026-03-30 |
| Companies | Position | End |
|---|---|---|
| ALPHATON CAPITAL CORP. | Director of Finance/CFO | 2025-10-23 |
| LINEAGE CELL THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2019-08-31 |
| AGEX THERAPEUTICS, INC. | Director of Finance/CFO | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
AlphaTON Capital Corp.
AlphaTON Capital Corp. BiotechnologyHealth Technology Operates as an immuno oncology company | Health Technology |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AgeX Therapeutics, Inc.
AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Health Technology |
Select your edition
All financial news and data tailored to specific country editions